
COLOPLAST-B (CBHD.DE) Fundamental Analysis & Valuation
FRA:CBHD • DK0060448595
Current stock price
56.66 EUR
+0.24 (+0.43%)
Last:
This CBHD.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CBHD.DE Profitability Analysis
1.1 Basic Checks
- In the past year CBHD was profitable.
- CBHD had a positive operating cash flow in the past year.
- In the past 5 years CBHD has always been profitable.
- In the past 5 years CBHD always reported a positive cash flow from operatings.
1.2 Ratios
- With an excellent Return On Assets value of 8.17%, CBHD belongs to the best of the industry, outperforming 88.71% of the companies in the same industry.
- CBHD has a Return On Equity of 28.90%. This is amongst the best in the industry. CBHD outperforms 95.16% of its industry peers.
- CBHD has a Return On Invested Capital of 12.85%. This is amongst the best in the industry. CBHD outperforms 88.71% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for CBHD is above the industry average of 10.01%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.17% | ||
| ROE | 28.9% | ||
| ROIC | 12.85% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
1.3 Margins
- CBHD has a Profit Margin of 14.30%. This is amongst the best in the industry. CBHD outperforms 83.87% of its industry peers.
- In the last couple of years the Profit Margin of CBHD has declined.
- Looking at the Operating Margin, with a value of 27.28%, CBHD belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
- In the last couple of years the Operating Margin of CBHD has declined.
- The Gross Margin of CBHD (67.87%) is better than 75.81% of its industry peers.
- In the last couple of years the Gross Margin of CBHD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.28% | ||
| PM (TTM) | 14.3% | ||
| GM | 67.87% |
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
2. CBHD.DE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CBHD is creating value.
- Compared to 1 year ago, CBHD has about the same amount of shares outstanding.
- CBHD has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, CBHD has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 3.09 indicates that CBHD is not in any danger for bankruptcy at the moment.
- CBHD has a better Altman-Z score (3.09) than 66.13% of its industry peers.
- CBHD has a debt to FCF ratio of 4.70. This is a neutral value as CBHD would need 4.70 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 4.70, CBHD is in line with its industry, outperforming 58.06% of the companies in the same industry.
- A Debt/Equity ratio of 1.55 is on the high side and indicates that CBHD has dependencies on debt financing.
- With a Debt to Equity ratio value of 1.55, CBHD is not doing good in the industry: 80.65% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.55 | ||
| Debt/FCF | 4.7 | ||
| Altman-Z | 3.09 |
ROIC/WACC2.34
WACC5.5%
2.3 Liquidity
- A Current Ratio of 1.30 indicates that CBHD should not have too much problems paying its short term obligations.
- CBHD has a Current ratio of 1.30. This is in the lower half of the industry: CBHD underperforms 62.90% of its industry peers.
- CBHD has a Quick Ratio of 1.30. This is a bad value and indicates that CBHD is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.81, CBHD is doing worse than 67.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.81 |
3. CBHD.DE Growth Analysis
3.1 Past
- CBHD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.16%.
- Measured over the past years, CBHD shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.02% on average per year.
- Looking at the last year, CBHD shows a small growth in Revenue. The Revenue has grown by 1.61% in the last year.
- Measured over the past years, CBHD shows a quite strong growth in Revenue. The Revenue has been growing by 8.49% on average per year.
EPS 1Y (TTM)-13.16%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%26.79%
Revenue 1Y (TTM)1.61%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.24%
3.2 Future
- Based on estimates for the next years, CBHD will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.92% on average per year.
- CBHD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.68% yearly.
EPS Next Y44.54%
EPS Next 2Y25.48%
EPS Next 3Y19.56%
EPS Next 5Y15.92%
Revenue Next Year3.43%
Revenue Next 2Y5.25%
Revenue Next 3Y5.8%
Revenue Next 5Y6.68%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. CBHD.DE Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 22.22 indicates a rather expensive valuation of CBHD.
- Based on the Price/Earnings ratio, CBHD is valued a bit cheaper than the industry average as 67.74% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 25.54, CBHD is valued at the same level.
- Based on the Price/Forward Earnings ratio of 15.14, the valuation of CBHD can be described as correct.
- CBHD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CBHD is cheaper than 66.13% of the companies in the same industry.
- CBHD's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.22 | ||
| Fwd PE | 15.14 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CBHD is valued a bit cheaper than 64.52% of the companies in the same industry.
- 80.65% of the companies in the same industry are more expensive than CBHD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.67 | ||
| EV/EBITDA | 12.4 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of CBHD may justify a higher PE ratio.
- A more expensive valuation may be justified as CBHD's earnings are expected to grow with 19.56% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y25.48%
EPS Next 3Y19.56%
5. CBHD.DE Dividend Analysis
5.1 Amount
- CBHD has a Yearly Dividend Yield of 5.38%, which is a nice return.
- In the last 3 months the price of CBHD has falen by -22.30%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- CBHD's Dividend Yield is rather good when compared to the industry average which is at 1.19. CBHD pays more dividend than 98.39% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, CBHD pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.38% |
5.2 History
- The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 129.96% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
- The dividend of CBHD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP129.96%
EPS Next 2Y25.48%
EPS Next 3Y19.56%
CBHD.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:CBHD (3/23/2026, 7:00:00 PM)
56.66
+0.24 (+0.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-06 2026-02-06/bmo
Earnings (Next)05-12 2026-05-12
Inst Owners29.4%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap11.91B
Revenue(TTM)27.89B
Net Income(TTM)3.99B
Analysts66.67
Price Target77.93 (37.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.38% |
Yearly Dividend2.94
Dividend Growth(5Y)5.3%
DP129.96%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-12.23%
Min EPS beat(2)-26.06%
Max EPS beat(2)1.6%
EPS beat(4)1
Avg EPS beat(4)-15.95%
Min EPS beat(4)-26.06%
Max EPS beat(4)1.6%
EPS beat(8)1
Avg EPS beat(8)-11.35%
EPS beat(12)1
Avg EPS beat(12)-9.84%
EPS beat(16)2
Avg EPS beat(16)-9.43%
Revenue beat(2)0
Avg Revenue beat(2)-2.64%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.48%
Revenue beat(4)0
Avg Revenue beat(4)-2.24%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-1.49%
Revenue beat(12)1
Avg Revenue beat(12)-1.7%
Revenue beat(16)3
Avg Revenue beat(16)-1.15%
PT rev (1m)-11.71%
PT rev (3m)-15.85%
EPS NQ rev (1m)-0.88%
EPS NQ rev (3m)-10.99%
EPS NY rev (1m)-1.61%
EPS NY rev (3m)-1.59%
Revenue NQ rev (1m)-0.35%
Revenue NQ rev (3m)-1.29%
Revenue NY rev (1m)-1.39%
Revenue NY rev (3m)-1.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.22 | ||
| Fwd PE | 15.14 | ||
| P/S | 3.19 | ||
| P/FCF | 16.67 | ||
| P/OCF | 12.95 | ||
| P/B | 6.45 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.4 |
EPS(TTM)2.55
EY4.5%
EPS(NY)3.74
Fwd EY6.61%
FCF(TTM)3.4
FCFY6%
OCF(TTM)4.38
OCFY7.72%
SpS17.76
BVpS8.79
TBVpS-10.43
PEG (NY)0.5
PEG (5Y)N/A
Graham Number22.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.17% | ||
| ROE | 28.9% | ||
| ROCE | 18.62% | ||
| ROIC | 12.85% | ||
| ROICexc | 13.21% | ||
| ROICexgc | 54.89% | ||
| OM | 27.28% | ||
| PM (TTM) | 14.3% | ||
| GM | 67.87% | ||
| FCFM | 19.14% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-ScoreN/A
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.55 | ||
| Debt/FCF | 4.7 | ||
| Debt/EBITDA | 2.36 | ||
| Cap/Depr | 104.29% | ||
| Cap/Sales | 5.5% | ||
| Interest Coverage | 12.72 | ||
| Cash Conversion | 75.69% | ||
| Profit Quality | 133.82% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 3.09 |
F-ScoreN/A
WACC5.5%
ROIC/WACC2.34
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.16%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%26.79%
EPS Next Y44.54%
EPS Next 2Y25.48%
EPS Next 3Y19.56%
EPS Next 5Y15.92%
Revenue 1Y (TTM)1.61%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.24%
Revenue Next Year3.43%
Revenue Next 2Y5.25%
Revenue Next 3Y5.8%
Revenue Next 5Y6.68%
EBIT growth 1Y3.15%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year25.11%
EBIT Next 3Y13.25%
EBIT Next 5Y11.53%
FCF growth 1Y24.69%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y24.41%
OCF growth 3Y9.24%
OCF growth 5Y6.9%
COLOPLAST-B / CBHD.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.
Can you provide the valuation status for COLOPLAST-B?
ChartMill assigns a valuation rating of 6 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
How financially healthy is COLOPLAST-B?
The financial health rating of COLOPLAST-B (CBHD.DE) is 4 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 44.54% in the next year.